Skip to main content
. 2020 Feb 10;12(2):408. doi: 10.3390/cancers12020408

Figure 3.

Figure 3

Interactions between HR for progression or death and sarcomatoid histology. Ipi = Ipilimumab; Nivo = Nivolumab; Sun=Sunitinib; Ave=Avelumab; Axi = Axitinib; Atez = Atezolizumab; Beva = bevacizumab; Pembro = pembrolizumab; Sun = sunitinib.